HARTALEGA HOLDINGS BERHAD

HARTALEGA HOLDINGS BERHAD stands as one of Malaysia’s most influential contributors to global healthcare — a company whose products protect lives across continents, often without recognition.

From hospitals and laboratories to industrial facilities and emergency response systems, its gloves form an invisible barrier between safety and exposure, making the company a critical participant in the global healthcare ecosystem. Though its products are rarely noticed individually, billions are used every year by medical professionals, frontline workers, and industries worldwide.

Its rise parallels Malaysia’s emergence as the world’s leading rubber glove manufacturing hub, yet Hartalega distinguished itself not merely through production scale, but through technological reinvention. By pioneering innovations in nitrile glove manufacturing and advanced automation systems, the company transformed what was once a labour-intensive commodity industry into a high-precision, technology-driven manufacturing sector.

Today, Hartalega is recognised globally as one of the world’s largest nitrile glove manufacturers, exporting to more than 70 countries while maintaining a strong focus on research, sustainability, and operational efficiency. Its products serve some of the world’s largest healthcare systems and institutions, quietly safeguarding millions of lives every day.

Its journey reflects a powerful truth — that the most essential protections are often the least visible.

Founder:

Kuan Kam Hon

Current Leadership:

Executive Chairman: Kuan Kam Hon

The leadership continues to guide the Group with a focus on innovation, advanced automation, sustainability, and global healthcare impact.

Some companies are built on demand — HARTALEGA was built on reinvention.

Before becoming a global healthcare manufacturing powerhouse, the business operated within property development during the 1980s. But when economic conditions weakened and the property market declined, founder Kuan Kam Hon recognised the need for transformation rather than retreat.

At the time, glove manufacturing was still an evolving industry dominated largely by latex products, with production methods that were labour-intensive and technologically limited. Yet within this uncertainty, he saw opportunity.

In 1988, Hartalega began operations with just a single production line.

The early years were defined not by scale, but by experimentation and engineering curiosity. Rather than competing purely on production volume, the company pursued something far more ambitious — technological differentiation.

This mindset eventually led to one of the industry’s most defining breakthroughs: the development of the world’s first lightweight nitrile glove.

At a time when latex allergies and contamination risks were becoming growing concerns within global healthcare systems, nitrile emerged as a safer alternative. Hartalega’s innovation accelerated the global transition away from latex, fundamentally reshaping the industry and positioning nitrile gloves as the preferred standard for modern medical protection.

But innovation did not stop at the product level.

The company also invested heavily in proprietary automation systems, engineering technologies capable of increasing production efficiency while reducing reliance on manual labour. This shift transformed glove manufacturing from a conventional industrial process into a highly automated precision manufacturing ecosystem.

As healthcare demand expanded globally, Hartalega scaled rapidly.

Production capacity grew from millions to billions of gloves annually, while exports expanded across North America, Europe, Asia, and emerging healthcare markets worldwide.

A major turning point arrived with the launch of the Next Generation Integrated Glove Complex (NGC) in 2013 — one of the world’s most advanced glove manufacturing facilities, designed around automation, efficiency, and scalability.

This was more than factory expansion.

It represented the industrialisation of innovation itself — combining robotics, intelligent production systems, energy efficiency, and high-speed manufacturing into a fully integrated ecosystem capable of serving global healthcare demand at unprecedented scale.

From a single production line to one of the world’s most advanced glove manufacturing operations, Hartalega’s journey reflects a powerful truth — that industries are transformed not only by demand, but by those willing to reinvent them entirely.

Core Activities:

• Manufacturing of nitrile and latex examination gloves

• Development of proprietary automation and production technologies

• Research and innovation in glove materials and performance

• Global export and distribution to healthcare and industrial sectors

• Integrated large-scale glove manufacturing operations

The Group focuses on combining manufacturing scale, automation efficiency, and product innovation to deliver high-quality protective solutions for global healthcare and industrial markets.

Notable Offerings Include:

• Nitrile examination gloves as core global product

• Lightweight and high-sensitivity gloves for medical applications

• Antimicrobial and coated gloves for enhanced protection

• Advanced automated glove manufacturing systems

• High-volume integrated production facilities for global export markets

These offerings position HARTALEGA HOLDINGS BERHAD as one of the world’s leading technology-driven glove manufacturers.

1988 — Establishment of HARTALEGA

1990s–2000s — Expansion of glove manufacturing operations and export markets

2000s — Breakthrough innovations in nitrile glove technology

2008 — Listed on Bursa Malaysia Main Board

2010 — Emerged as world’s largest nitrile glove producer

2013 — Launch of Next Generation Integrated Glove Complex (NGC)

2018 — Became one of Malaysia’s largest listed companies by market capitalisation

2020s — Continued global expansion, automation enhancement, and healthcare manufacturing leadership

HARTALEGA HOLDINGS BERHAD has played a transformative role in shaping the global healthcare manufacturing landscape.

Its most significant contribution lies in pioneering the worldwide transition from latex to nitrile gloves — a shift driven by improved safety, allergy reduction, durability, and infection control standards within healthcare environments.

By developing lightweight nitrile glove technologies, the company helped redefine industry expectations regarding comfort, sensitivity, and protective performance, accelerating nitrile adoption across hospitals, laboratories, and healthcare systems worldwide.

Hartalega also transformed the manufacturing side of the industry itself.

Through heavy investment in proprietary automation and process engineering, the company advanced glove manufacturing from a labour-intensive operation into a high-efficiency industrial ecosystem driven by technology and precision engineering.

This innovation strengthened Malaysia’s global leadership position within the rubber glove industry, helping establish the country as the world’s dominant glove manufacturing hub.

Beyond economics, the company’s impact extends directly into public health infrastructure.

Its products became critical during periods of heightened global healthcare demand, particularly during pandemics and medical emergencies where protective equipment became essential for frontline safety.

Supplying gloves to more than 70 countries, Hartalega became part of the invisible infrastructure supporting global healthcare systems, infection prevention, diagnostics, and emergency response operations worldwide.

Its broader contribution lies in demonstrating how Malaysian manufacturing can evolve beyond commodity production into innovation-led industrial leadership.

By combining automation, engineering capability, research, and scalability, Hartalega positioned itself not simply as a manufacturer, but as a global healthcare technology player.

Some companies manufacture products — HARTALEGA manufactures protection itself.

From a single production line to one of the world’s most advanced glove manufacturing ecosystems, its legacy is not measured merely in billions of gloves produced, but in the lives safeguarded through them.

Quietly operating behind hospitals, laboratories, clinics, and healthcare systems across continents, the company became part of the unseen defence infrastructure protecting professionals, patients, and communities every day.

Its journey reflects a defining truth of modern healthcare — that the most powerful innovations are often not the most visible, but the ones standing silently between life and risk.